Morrison Foerster is an international law firm with lawyers practicing throughout the United States, Asia, and Europe. Click to discover more.

mofo_share_image.jpg

Morrison Foerster

common-default.jpeg

Terms / Notices

Cookies

Privacy Policy

Reporting Hotline

Attorney Advertising

Alumni

  Linkedin

MoFo LinkedIN

  Facebook

MoFo Facebook

YouTube

MoFo Youtube

Morrison Foerster - Footer

Three MoFo Lawyers Named in IAM’s 2025 Strategy 300: World’s Leading IP Strategists Guide

You have not solved the recaptcha challenge yet or session expired, try again.

Email Disclaimer

Disclaimer

Unsolicited e-mails and information sent to Morrison Foerster will not be considered confidential, may be disclosed to others pursuant to our <a href="https://www.mofo.com/about/privacy-policy.html">Privacy Policy</a>, may not receive a response, and do not create an attorney-client relationship with Morrison Foerster. If you are not already a client of Morrison Foerster, do not include any confidential information in this message. Also, please note that our attorneys do not seek to practice law in any jurisdiction in which they are not properly authorized to do so.

Feedback

mofo-logo-2022.svg

People

Capabilities

Resources

About

Community

Offices

Careers

Stay Connected

MoFo partners Rich Hung, Bita Rahebi, and Janet Xiao have been named to the Strategy 300: World’s Leading IP Strategists guide by...

<h3>Sorry, we weren’t able to find the terms you entered.</h3>Please try a different term or keyword.

People

Capabilities

Resources

Not Found Cards

About Morrison Foerster

people-default-header-desktop.jpg

people-default-header-mobile.jpg

Default Meta Data

MoFo partners Rich Hung, Bita Rahebi, and Janet Xiao have been named to the Strategy 300: World’s Leading IP Strategists guide by Intellectual Asset Management (IAM). According to the publication, the 2025 edition of the Strategy 300 identifies individuals “driving innovation and unlocking value through intellectual property across industries and continents.”Rich Hung currently co-chairs Morrison Foerster’s Global Litigation Department. He previously co-led the firm’s IP Litigation Group and the cross-disciplinary Intellectual Property Group for over a decade. A seasoned trial lawyer, Rich has taken over a dozen cases to jury verdict or final award and overseen well over 150 distinct IP disputes. With his background as an electrical engineer, Federal Circuit clerk, and registered patent lawyer, Rich also regularly represents clients in adversarial licensing disputes.Bita Rahebi, co-chair of Morrison Foerster’s Global IP Litigation Group and the cross-disciplinary Intellectual Property Group, and co-leader of its Semiconductor Industry Group, helps the world’s most innovative technology companies protect their most valuable assets. She provides strategic direction and leads complex, high-stakes litigation matters. As a trial lawyer, Bita is known for zealously representing her clients’ interests. She brings an ability to explain complicated issues to juries and judges, a skill honed through years of experience working with cutting-edge technologies.Janet Xiao, a partner in MoFo’s Palo Alto office, is a leading IP strategist for life sciences companies, advising on global patent portfolio management, IP due diligence, and cross-border transactions. She counsels clients ranging from biotech startups to multinational pharmaceutical companies on biopharmaceuticals, cell and gene therapies, research tools, and diagnostics. As Head of the firm’s China Life Sciences Group, Janet is recognized for her expertise in U.S./China IP matters and praised by Chambers Global for her strategic insight and technical depth.IAM’s Strategy 300: World’s Leading IP Strategists guide celebrates professionals who not only excel in IP law but also lead the way in transforming intellectual property portfolios into strategic business assets. Honorees represent a diverse range of organizations—including global corporations, top-tier service providers, research institutions, and universities—and are recognized for their work in high-stakes transactions and innovative monetization strategies. Each individual named to the list was selected through confidential nominations and rigorous research, including interviews with senior IP executives across North America, Europe, and Asia, ensuring that every honoree exemplifies excellence, influence, and impact in the global IP landscape. To view the full list of honorees, visit the organization’s <a href="https://www.iam-media.com/article/global-ip-leaders-recognised-in-iams-2025-strategy-300" target="_blank">website</a>.

Three MoFo Lawyers Named in IAM’s 2025 Strategy 300: World’s Leading IP Strategists Guide

Sign Up

Rich is the Global Co-Chair of Morrison Foerster’s Litigation Department. He previously co-led the firm’s IP Litigation Group and the cross–disciplinary Intellectual Property Group for over a decade. He brings his knowledge as a registered patent lawyer and a Federal Circuit clerk to lead complex technology matters for clients in state and federal trial and appellate courts. He has represented plaintiffs and defendants in high–stakes patent litigation, competitor‑on–competitor cases, non–practicing entity assertions, and trade secret misappropriation disputes—obtaining consent judgments in multiple cases. Rich also represents clients in adversarial proceedings before the U.S. PTO and counsels clients on strategic offensive and defensive patent licensing and acquisition issues. His matters have spanned a broad range of technologies, including:<ul><li>Internet search</li><li>Cryptography</li><li>Programmable logic devices</li><li>Graphical user interfaces</li><li>Smartphones</li><li>Water filtration consumer appliances</li></ul>Rich earned dual bachelor’s degrees in electrical engineering and economics from Stanford University and his law degree from Columbia Law School. In law school, he externed for the Honorable Sonia Sotomayor, then with the Southern District of New York. He was also a James Kent Scholar, a moot court editor and judge, and a recipient of the Carroll G. Harper Prize for excellence in intellectual property. After law school, Rich clerked for the Honorable Paul Michel of the U.S. Court of Appeals for the Federal Circuit.In 2014, Rich was appointed by then San Francisco Mayor Edwin Lee to serve as a Neutral Commissioner on the San Francisco Rent Stabilization and Arbitration Board. He served two terms as President and remains on the board of directors of the Asian Law Alliance, a non-profit organization that provides pro bono legal assistance to the Asian/Pacific Islander community in the Silicon Valley. Rich is a Fellow of the American Bar Foundation.Rich previously tried multiple criminal cases—all to favorable verdicts—with the San Francisco District Attorney’s Office.

Richard Hung

Co-Chair, Litigation Department

Bita Rahebi serves as co-chair of Morrison Foerster’s global IP Litigation Group and cross-disciplinary Intellectual Property Group and is a co-leader of its Semiconductor Industry Group. The world’s largest and most innovative technology companies turn to Bita for her trial skills and her strategic direction leading complex, high-stakes litigation matters. She litigates before state and federal trial courts, the Federal Circuit, and the International Trade Commission on a wide range of matters involving semiconductors, software, consumer electronics, medical devices, and standard essential patents (SEPs).As a trial lawyer, Bita is known for zealously representing her clients’ interests. She brings an ability to explain complicated issues to juries and judges, a skill honed through years of experience working with cutting-edge technologies. She has obtained a complete defense victory as lead trial lawyer, invalidated numerous patents, and also obtained winning results for plaintiffs.Bita’s successes as an attorney have built her reputation as a recognized leader for intellectual property litigation. Chambers USA noted that Bita “offers substantial expertise handling patent disputes for technology-sector clients,” and clients have called her a “razor-sharp” lawyer who “excels at trial and litigation strategy” and is “client focused.” Bita’s accolades include:<ul><li>Named to Forbes’ List of America’s Top 250 Lawyers</li><li>Named a Top Intellectual Property Lawyer by Daily Journal for multiple years</li><li>Recognized for Intellectual Property: Patent Litigation, California in the 2022–2024 Chambers USA guides</li><li>Selected as Intellectual Property, Women Leader in Tech Law 2024 by The Recorder</li><li>Named a Leading IP Strategist, IAM Strategy 300 2024</li><li>Recognized in “Leaders of Influence: Litigators & Trial Attorneys” in 2023 by the Los Angeles Business Journal</li><li>Named to IAM’s Patent 1000 list for Litigation (2022–2024)</li></ul>Bita’s litigation practice includes patent, trade secrets, and copyright litigation. Additionally, Bita advises clients on strategic transactional issues and negotiates on behalf of clients in patent licensing discussions. Bita has also successfully tried criminal jury matters at the Los Angeles City Attorney’s Office, securing a guilty verdict for every trial.Bita is the past president of the Los Angeles Intellectual Property Law Association and she co-founded the organization’s Women in IP committee. She also served as a Ninth Circuit Judicial Conference Lawyer Representative.Earning her B.A. from the University of California, Berkeley, she served as president and editor-in-chief of the Daily Californian. She received her J.D. from the University of California, Los Angeles, where she was an editor of the UCLA Law Review.<h4>Representative Experience:</h4><ul><li>Nevro Corp. v. Stimwave Technologies Inc. (District of Delaware). Represented Nevro Corp., a public global medical device company, in its patent battle against competitor Stimwave Technologies, Inc. Secured a preliminary injunction for Nevro, after an all-day evidentiary hearing. The case subsequently settled after Stimwave stipulated to a permanent injunction agreeing not to infringe the patents.</li><li>Lamar v. Beats, Dr. Dre, and Jimmy Iovine (LA Superior Court). Represented Defendants in a breach of written royalty agreement involving the design of Beats headphones.</li><li>Analog Devices v. Xilinx Inc. (District of Delaware). Represented Xilinx in a 16-patent case, including a counterclaim by Xilinx against ADI.</li><li>Farstone Technology, Inc. v. Apple Inc. (Central District of California). Represented Apple in a patent infringement suit against Farstone Technology Inc. Secured a victory for Apple and invalidated the asserted patent on Williamson grounds. The decision was affirmed by the Federal Circuit.</li><li>AirWatch, LLC v. Good Technology Corp. (Northern District of Georgia; District of Delaware). Represented AirWatch in patent infringement actions against Good and also defended AirWatch in a patent infringement action in D. Delaware.</li><li>Digital Empire v. Compal Electronics (Southern District of California). Lead counsel defending original design manufacturer and three of its subsidiaries in patent infringement action; successfully obtained order for fees and costs under 35 U.S.C. § 285 (exceptional case).</li><li>eTool Development, Inc. v. National Semiconductor Corporation (Eastern District of Texas). Represented Texas Instruments (formerly National Semiconductor) in a patent infringement lawsuit involving online configuration software. Prevailed on summary judgment on two separate non-infringement grounds. Successfully defeated motion for reconsideration.</li><li>Cypress Semiconductor v. Altera Corporation (Santa Clara Superior Court). Represented Altera Corporation in trade secrets litigation brought by Cypress Semiconductor concerning programmable logic devices. A favorable settlement was reached prior to trial.</li></ul>

Bita Rahebi

Partner

Dr. Janet (Jian) Xiao is a leading patent attorney specializing in global patent procurement, patent portfolio management, and IP strategic planning for life sciences and biopharmaceutical companies. Recognized by Chambers USA and Chambers Global as a top-ranked intellectual property lawyer, Dr. Xiao is highly sought after by biotech and pharmaceutical innovators worldwide for patent prosecution, patent strategy, and life sciences IP counsel.Dr Xiao’s clients range from large renowned multinational companies to emerging startups worldwide. She advises her clients on patent matters relating to various technologies including antibody therapeutics, cell therapeutics, nanomedicine, gene therapy, drug delivery systems, diagnostics, and nutraceuticals. Recognized for her deep understanding of the industry and knowledge of IP, Janet is known for developing and strengthening her clients’ complex patent portfolios to maximize their commercial value and success. She has been instrumental on the strategy development for multibillion-dollar patent portfolios for pharmaceutical clients, and adds tremendous value by combining her creative legal skills, keen business acumen, and solid foundation in science. As impressed clients noted to Chambers, “Janet consistently delivers a very high level of client service and exhibits strong commercial awareness and vision.”Janet works extensively in performing IP due diligence reviews in the contexts of VC investments, technology transactions, mergers and acquisitions, as well as marketing and manufacturing clearance forbiopharmaceutical products. She works closely with her clients to assess potential risks and devise preemptive risk-management strategies for their product development and investments. She has led hundreds of IP due diligence projects, and is most notable for her deep knowledge about patent landscapes in the fields of cancer immunotherapy, gene editing, next-generation sequencing, liquid biopsy, antibody manufacturing, and medical devices. Janet works synergistically with patent litigators in the event of legal challenges by third-party competitors or vice versa, and is frequently called upon to represent clients in litigation and post-grant proceedings.Janet is among the very few IP attorneys in the world who are both equipped with solid skills in global strategic IP management and knowledgeable about IP issues unique to China and Chinese clients, and she has been the go-to counsel for IP issues in U.S./China cross-border transactions and operations in China. As Chambers Global 2024 notes, “She is great, very strong and thoughtful. She has a very large contingent of Chinese companies.”Janet is the Head of China Life Sciences at Morrison Foerster and served as co-chair of the firm’s global Life Sciences Group from 2016 to 2019. Chambers Global states that Janet “is recognized for her knowledge of IP law relating to the life sciences arena,” and that she is “held in high regard by sources for her deep understanding of the pharmaceutical and biotech industries.” In a recent edition of Chambers Global, a client remarks, “Janet is a wonderful lawyer. She is very experienced in advising life sciences clients doing business in China and the US. She is highly responsive and always gives practical advice. Her IP expertise adds tremendous value to our business.”

肖荐（Janet Xiao）博士的业务侧重于为生命科学公司处理在全球范围内的专利采购、专利组合管理和战略策划事宜。肖博士服务的客户范围广泛，包括大型跨国生物制药公司，例如赛尔基因公司（Celgene）和基因泰克公司（Genentech），也包括全球范围的新兴创业公司。她经常就与各种技术有关的专利事宜向客户提供法律意见，其中涉及的技术包括抗体疗法、细胞疗法、纳米医学、基因疗法、给药系统、诊断和和营养学等。来自全球的创新者纷纷向肖博士寻求专利申请和专利战略的法律咨询，这一点也得到了《钱伯斯指南》的认可。她帮助客户开发和加强其复杂的专利组合，从而为客户实现最大的商业价值。在为制药行业的客户制定数十亿美元专利组合的战略方面，肖博士发挥着重要的作用。《钱伯斯指南》曾引用客户评价称，“肖博士是我曾合作过的律师当中知识最渊博、效率最高的一位律师。她能很好地将专利组合的历史信息用于全球专利申请问题上。”肖博士针对风险投资、技术交易、并购和生物医药产品的市场推广与生产许可事宜开展广泛的知识产权尽职调查审查工作。她协助世界上一些最成功的生物制药公司和投资者，为其产品开发和投资评估潜在风险，并制定先发制人的风险管理策略。她曾牵头处理过数百个知识产权尽职调查项目，并凭借自己对癌症免疫治疗、基因编辑、新一代测序、液体活检、抗体制造和医疗设备领域的专利方面的深厚知识而闻名。肖博士时常与专利诉讼律师合作，处理由第三方竞争者提出的法律质疑，或对第三方竞争者提出的法律质疑，她还经常受聘代表客户处理专利诉讼和授予后程序。肖博士是美富中国生命科学业务组主管，她曾在2016至2019期间担任美富全球生命科学业务组的联席主管。肖博士是全球为数不多的既拥有很强的全球战略性知识产权管理技能，同时又对中国和中国客户独特的知识产权问题具有深刻理解的知识产权律师之一，她一直是处理中美跨境交易和在中国境内经营中所涉知识产权问题的首选律师。《钱伯斯全球指南》称赞她是一位优秀的知识产权律师，“她因处理与复杂跨境交易有关的知识产权问题工作而知名，经常代表中国客户处理这方面的事宜” 。在近期一版《钱伯斯全球指南》中，某客户评价称，“肖博士在为于中国和美国开展业务的生命科学客户提供法律意见方面，有非常丰富的经验。她非常负责而且总是提供切实可行的法律意见。她在知识产权方面的专业意见为我们的业务增添了巨大价值。”自2005年以来，肖博士一直积极参与北美华人生物医药协会（CABS）的领导工作。该协会是一家非营利组织，致力于成为连接中美两国生命科学领域的纽带。肖博士在2011至2012年间担任该协会主席。她还是百华协会（BayHelix）的成员。百华协会是一家非营利组织，由全球生命科技和医疗保健产业领域的华人精英组成。

Janet Xiao

Semiconductors

Litigation

Rich Hung, Bita Rahebi, and Janet Xiao recognized for their individual achievements